News
Advanced autofluorescence reveals cellular pigment reservoirs with therapeutic potential at the 2025 International Spectralis Symposium – and Beyond.
Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, as shared at the Heidelberg 2025 International SPECTRALIS Symposium – And ...
· Eat a healthy diet, including fruits and vegetables (especially dark leafy greens like spinach or kale) and fish high in ...
Estimates suggest that the NHS could save over £1bn annually through the adoption of optical coherence tomography technology ...
A Bristol-based health technology start-up has trialled its "groundbreaking" sight-loss prevention technology as it becomes ...
1 AMD threatens distance as well as reading acuity ... In conclusion, the lesion size and the macular thickness decreased in the Avastin group. The OCT and FA showed that the macula turns dry and ...
Age-related macular degeneration (AMD) is a major cause of blindness, especially in older adults. A key feature of early AMD ...
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...
To evaluate long-term outcomes of anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) in the Netherlands (NL), where bevacizumab is the mandated first-line drug, compared to high ...
4d
Pharmaceutical Technology on MSNOutlook’s wet AMD treatment accepted by SMC for NHS ScotlandThe Scottish Medicines Consortium (SMC) has accepted Outlook Therapeutics’ Lytenava (bevacizumab gamma) for the treatment of ...
Disorganization of retinal inner layers (DRIL) is likely an important biomarker signaling visual deterioration in patients with diabetic macular ischemia (DMI), and overall causes for functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results